| PERIOD ENDING | 4-Jul-09 | 4-Apr-09 | 3-Jan-09 | 27-Sep-08 | | Total Revenue | 155,298 | 133,000 | 148,451 | 236,227 | | Cost of Revenue | 113,353 | 103,543 | 129,369 | 177,745 | | | Gross Profit | 41,945 | 29,457 | 19,082 | 58,482 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 15,446 | 14,757 | 15,709 | 15,371 | | Non Recurring |
-
|
-
| 15,914 |
-
| | Others | 6,223 | 5,937 | 6,997 | 5,799 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 20,276 | 8,763 | (19,538) | 37,312 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (218) | (237) | (139) | 97 | | Earnings Before Interest And Taxes | 20,058 | 8,526 | (19,677) | 37,409 | | Interest Expense | 784 | 658 | 684 | 714 | | Income Before Tax | 19,274 | 7,868 | (20,361) | 36,695 | | Income Tax Expense | 7,575 | 3,058 | (6,389) | 13,701 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 11,699 | 4,810 | (13,972) | 22,994 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 11,699 | 4,810 | (13,972) | 22,994 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $11,699 | $4,810 | ($13,972) | $22,994 |
|
0.26% Nasdaq 
Income Statement
